Trial of Simplified Treatment Monitoring for 8 Weeks Glecaprevir/Pibrentasvir in Chronic Hepatitis C Patients

NCT03117569 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

380

Enrollment

OTHER_GOV

Sponsor class

Conditions

Hepatitis C, Chronic

Interventions

DRUG: glecaprevir (300mg)/pibrentasvir (120mg)

Sponsor

Kirby Institute